Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
Search /vufind/Search2/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
PubPharm (23.556)
1
A study to compare treatment after surgery of abemaciclib combined with standard endocrine therapy versus endocrine therapy alone in patients with early stage breast cancer : A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High-Risk, Node-Positive, Early-Stage, Hormone Receptor-Positive, Human Epidermal Receptor 2-Negative, Breast Cancer - MonarchE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Study with investigational drug PF-06463922 and comparator crizotinib in patients with a specific type of advanced lung cancer : A Phase 3, randomized, open label study of lorlatinib (PF 06463922) monotherapy versus crizotinib monotherapy in the first line treatment of patients with advanced ALK positive non small cell lung cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
An Extension Study of AG-348 in Adult Subjects with Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies : An Open-Label, Multicenter, Extension Study of AG-348 in Adult Subjects with Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A study to compare the efficacy and safety of bb2121 to standard treatment in people who have Myeloma that is not responsive after treatment or who had Myeloma which has returned after a period of treatment. : A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of BB2121 Versus Standard Triplet Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (Rrmm) (KarMMa-3)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Study to Evaluate the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma : A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL COMPARING THE EFFICACY AND SAFETY OF POLATUZUMAB VEDOTIN IN COMBINATION WITH RITUXIMAB AND CHP (R-CHP) VERSUS RITUXIMAB AND CHOP (R-CHOP) IN PREVIOUSLY UNTREATED PATIENTS WITHDIFFUSE LARGE B-CELL LYMPHOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A trial of oral azacitidine compared to standard treatment in patients with relapsed lymphoma. : Randomized Phase 3 Study evaluating the Efficacy and the Safety of Oral Azacitidine (CC-486) compared to Investigator’s Choice Therapy in Patient with Relapsed or Refractory Angioimmunoblastic T cell Lymphoma - ORACLE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A study evaluating the efficacy and safety of ralinepag in treatment of patients with pulmonary hypertension. : A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients - ADVANCE-Outcomes
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Phase III, Randomized, Double-blind Trial Comparing Trastuzumab Plus Chemotherapy and Pembrolizumab With Trastuzumab Plus Chemotherapy and Placebo as First-line Treatment in Participants With HER2 Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (KEYNOTE 811) : A Phase III, Randomized, Double-blind Trial Comparing Trastuzumab Plus Chemotherapy and Pembrolizumab With Trastuzumab Plus Chemotherapy and Placebo as First-line Treatment in Participants With HER2 Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (KEYNOTE 811)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A review of the LightPath Imaging System using the tracer 68Ga-RM2 in helping to show the boundaries of the breast cancer during removal of the tumour. : Evaluation of the LightPath Imaging System and the PET tracer 68Ga-RM2 in wide local excision (WLE) for breast cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
BRCA-P: A Cancer Prevention study to determine if Denosumab can prevent Breast Cancer Development in Women carrying a BRCA1 Germline Mutation : BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to determine the Preventive Effect of Denosumab on Breast Cancer in Women carrying a BRCA1 Germline Mutation - BRCA-P
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2356]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 3
Medienart
23.556
Aufsätze
23.556
E-Artikel
23.556
E-Ressourcen
Zeitschriftentitel
23.556
WHO International Clinical Trials Registry Plat...
Thema
23.556
610
Phase: Phase 3
23.556
Recruitment Status: Authorised-recruitment may ...
23.556
Study Type: Interventional
122
Medical Condition: Moderately to Severely Activ...
108
Medical Condition: Diabetes Mellitus, Type 2 Me...
92
Medical Condition: Multiple Myeloma MedDRA vers...
82
Medical Condition: Cystic Fibrosis MedDRA versi...
76
Medical Condition: Atopic Dermatitis MedDRA ver...
66
Medical Condition: Mild cognitive impairment (M...
64
Medical Condition: Moderately to Severely Activ...
60
Medical Condition: Myelofibrosis MedDRA version...
58
Medical Condition: Moderate and Severe Atopic D...
58
Medical Condition: Pulmonary Arterial Hypertens...
58
Medical Condition: Ulcerative Colitis MedDRA ve...
56
Medical Condition: Multiple sclerosis MedDRA ve...
56
Medical Condition: hidradenitis suppurativa Med...
54
Medical Condition: Multiple myeloma MedDRA vers...
50
Medical Condition: Chronic Obstructive Pulmonar...
50
Medical Condition: Chronic Spontaneous Urticari...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
18.764
2020-
4.792
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
23.152
Englisch
334
Unbestimmt
32
Französisch
10
Deutsch
10
Italienisch
4
Dänisch
4
Niederländisch
4
Schwedisch
2
Finnisch
2
Polnisch
2
Spanisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...